LGND - Ligand Pharmaceuticals launches biopharmaceutical company Pelthos Therapeutics
2024-04-03 09:23:59 ET
More on Ligand Pharmaceuticals
- Ligand Pharmaceuticals Inc. (LGND) Q4 2023 Earnings Call Transcript
- Ligand Pharmaceuticals gains amid bullish investor pitch
- Ligand Pharmaceuticals Non-GAAP EPS of $1.05 beats by $0.39, revenue of $28.1M beats by $2.46M
- Seeking Alpha’s Quant Rating on Ligand Pharmaceuticals
- Historical earnings data for Ligand Pharmaceuticals